Search Result "nucleoside-5'-triphosphate"
Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 6 Year: 2012 Page: 739-750
Author(s): Carla D. Bonan
Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold
Journal: Medicinal Chemistry
Volume: 16 Issue: 5 Year: 2020 Page: 689-702
Author(s): Saira Afzal,Sumera Zaib,Behzad Jafari,Peter Langer,Joanna Lecka,Jean Sévigny,Jamshed Iqbal
Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 2-15
Author(s): Deepti Chopra,Bharti Bhandari
Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications
Journal: Current Neuropharmacology
Volume: 17 Issue: 1 Year: 2019 Page: 84-98
Author(s): Ivana GrkoviÄ,Dunja DrakuliÄ,Jelena MartinoviÄ,NataÅ¡a MitroviÄ
Purinergic Modulation and CD39/ENTPD1 in Cancer
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Lili Feng,Elliot B. Tapper,Xiaofeng Sun,Marina Gehring,Simon C. Robson,Yan Wu
Doi: 10.2174/978160859225114040008
Computer-Aided Drug Design Methodologies Toward the Design of Anti-Hepatitis C Agents
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 8 Year: 2012 Page: 802-813
Author(s): Alejandro Speck-Planche,M. Natalia D. S. Cordeiro
Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 39 Year: 2016 Page: 4396-4417
Author(s): Norma Alva,Ronald Alva,Teresa Carbonell
Partial A1 Adenosine Receptor Agonists from a Molecular Perspective and Their Potential Use as Chronic Ventricular Rate Control Agents During Atrial Fibrillation (AF)
Journal: Current Topics in Medicinal Chemistry
Volume: 4 Issue: 8 Year: 2004 Page: 839-854
Author(s): Jeff A. Zablocki, Lin Wu, John Shryock, Luiz Belardinelli